Seiz, Lina;Kotzsch, M;Sweep, F;Fuessel, S;Lossnitzer, A;Schmitt, M;Magdolen, V.KALLIKREIN-RELATED PEPTIDASE 4 (KLK4)-A POTENTIAL BIOMARKER IN PROSTATE CANCER.Tumour Biol.2010.31 1.S62-S63

Bittner, T;Albert, MH;Nonoyama, S;Notarangelo, LD;Burns, S;Imai, K;Espanol, T;Fasth, A;Pellier, I;Strauss, G;Morio, T;Gathmann, B;Noordzij, JG;Fillat, C;Hoenig, M;Nathrath, M;Meindl, A;Pagel, P;Wintergerst, U;Fischer, A;Thrasher, AJ;Belohradsky, BH;Ochs, HD.X-Linked Thrombocytopenia (XLT) Due to WAS Mutations: Clinical Characteristics, Long-Term Outcome, and Treatment Options.Clin Immunol.2010.135.2.15 -

Fletcher, O;Johnson, N;Dos Santos Silva, I;Orr, N;Ashworth, A;Nevanlinna, H;Heikkinen, T;Aittomäki, K;Blomqvist, C;Burwinkel, B;Bartram, CR;Meindl, A;Schmutzler, RK;Cox, A;Brock, I;Elliott, G;Reed, MW;Southey, MC;Smith, L;Spurdle, AB;Hopper, JL;Couch, FJ;Olson, JE;Wang, X;Fredericksen, Z;Schürmann, P;Waltes, R;Bremer, M;Dörk, T;Devilee, P;van Asperen, CJ;Tollenaar, RA;Seynaeve, C;Hall, P;Czene, K;Humphreys, K;Liu, J;Ahmed, S;Dunning, AM;Maranian, M;Pharoah, PD;Chenevix-Trench, G;Beesley, J;Bogdanova, NV;Antonenkova, NN;Zalutsky, IV;Anton-Culver, H;Ziogas, A;Brauch, H;Ko, YD;Hamann, U;Fasching, PA;Strick, R;Ekici, AB;Beckmann, MW;Giles, GG;Severi, G;Baglietto, L;English, DR;Milne, RL;Benitez, J;Arias, JI;Pita, G;Nordestgaard, BG;Bojesen, SE;Flyger, H;Kang, D;Yoo, KY;Noh, DY;Mannermaa, A;Kataja, V;Kosma, VM;Garcia-Closas, M;Chanock, S;Lissowska, J;Brinton, LA;Chang-Claude, J;Wang-Gohrke, S;Broeks, A;Schmidt, MK;van Leeuwen, FE;Van't Veer, LJ;Margolin, S;Lindblom, A;Humphreys, MK;Morrison, J;Platte, R;Easton, DF;Peto, J.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls..Cancer Epidemiol Biomarkers Prev.2010.19.9.2143-51

Magdolen, V;Seweryn, P;Schmitt, M;Beaufort, N.The human fibrinolytic system is a target for proteases secreted by the pathogenic bacterium.J Thromb Haemost.2010.8.8-8

Kotzsch, M;Bernt, K;Friedrich, K;Luther, E;Albrecht, S;Gatzweiler, A;Magdolen, V;Baretton, G;Zietz, C;Luther, T.Prognostic relevance of tumour cell-associated uPAR expression in invasive ductal breast carcinoma..Histopathology.2010.57.3.461-71

Ohler, A;Debela, M;Wagner, S;Magdolen, V;Becker-Pauly, C.Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation..Biol Chem.2010.391.4.455-60

Taubert, H;Würl, P;Greither, T;Kappler, M;Bache, M;Lautenschläger, C;Fussel, S;Meye, A;Eckert, AW;Holzhausen, HJ;Magdolen, V;Kotzsch, M.Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients..Br J Cancer.2010.102.4.731-7

Goettig, P;Magdolen, V;Brandstetter, H.Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)..Biochimie.2010.92.11.1546-67

Mengele, K;Napieralski, R;Magdolen, V;Reuning, U;Gkazepis, A;Sweep, F;Brünner, N;Foekens, J;Harbeck, N;Schmitt, M.Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1..Expert Rev Mol Diagn.2010.10.7.947-62

Gratio, V;Beaufort, N;Seiz, L;Maier, J;Virca, GD;Debela, M;Grebenchtchikov, N;Magdolen, V;Darmoul, D.Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells..Am J Pathol.2010.176.3.1452-61